Apigenin Delays Postovulatory Oocyte Aging by Reducing Oxidative Stress Through SIRT1 Upregulation

Xuerui Yao,Panpan Guo,Ying-Hua Li,Hao Guo,Zhelong Jin,Wen Lui,Jianbin Yuan,Qingshan Gao,Lin Wang,Yunxiao Li,Jiabin Shi,Xiwei Zhang,Qilong Cao,Yong-Nan Xu,Nam-Hyung Kim
DOI: https://doi.org/10.1016/j.theriogenology.2024.01.007
IF: 2.923
2024-01-01
Theriogenology
Abstract:After ovulation, senescent oocytes inevitably experience reduced quality and defects in embryonic development. Apigenin (API) is a flavonoid with a wide range of pharmacological effects. Therefore, this study examined the protective effects of API on the quality of porcine oocytes during in-vitro ageing and the underlying mechanisms. The results showed that API treatment could reduce the activation rate after aging for 48 h. In addition, API significantly reduced reactive oxygen species, abnormal distribution of mitochondria, early apoptosis in ageing oocytes, increased glutathione, and mitochondrial adenosine triphosphate levels in ageing oocytes. Importantly, API increased the embryonic development rate in aged oocytes. We also examined molecular changes, finding decreased sirtuin 1 expression in in-vitro postovulatory oocytes, but API reversed this effect. Our results suggest that API attenuates the deterioration of oocyte quality during in-vitro ageing, possibly by reducing oxidative stress through the upregulation of sirtuin 1.
What problem does this paper attempt to address?